Published in West J Med on September 01, 1975
Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet (1970) 11.61
DNA polymerase associated with human hepatitis B antigen. J Virol (1973) 10.71
An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A (1968) 7.33
New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol (1972) 6.33
A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA (1965) 6.21
Viral hepatitis. New light on an old disease. JAMA (1970) 6.03
Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science (1973) 5.82
Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science (1970) 5.81
New antigen-antibody system in Australia-antigen-positive hepatitis. Lancet (1971) 5.41
The heterogeneity of Australia antigen. J Infect Dis (1971) 4.35
Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology (1972) 4.29
Antibody to hepatitis-B-virus core in man. Lancet (1973) 4.24
Hepatitis antigen. Correlation with disease and infectivity of blood-donors. Lancet (1969) 4.03
Detection of Australia antigen and antibody by means of radioimmunoassay techniques. J Infect Dis (1970) 3.89
Australia antigen: large-scale purification from human serum and biochemical studies of its proteins. J Virol (1971) 3.28
Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. J Immunol (1971) 2.98
Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet (1974) 2.77
A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis (1969) 2.58
Detection of additional antigenic determinants of hepatitis B antigen. J Immunol (1972) 2.57
ACQUIRED CYTOMEGALOVIRUS INFECTION: ASSOCIATION WITH HEPATOMEGALY AND ABNORMAL LIVER-FUNCTION TESTS. N Engl J Med (1965) 2.46
Biophysical properties of Australia antigen. J Virol (1969) 2.45
Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive hemagglutination methods. J Immunol (1971) 2.35
Australia antigen and hepatitis. N Engl J Med (1970) 2.35
Immunologic distinction between infectious and serum hepatitis. N Engl J Med (1970) 2.16
Further studies on a "new" human isoprecipitin system (Australia antigen). Blood (1966) 2.16
Prevention of endemic HAA-positive hepatitis with gamma globulin. Use of a simple radioimmune assay to detect HAA. N Engl J Med (1972) 2.00
Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication. N Engl J Med (1974) 1.98
Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen. N Engl J Med (1974) 1.92
Specificity of the direct solid-phase radioimmunoassay for detection of hepatitis-B antigen. Lancet (1973) 1.89
Transmission of serum hepatitis. JAMA (1970) 1.84
A new antigen-antibody system. Clinical significance in long-term carriers of hepatitis B surface antigen. JAMA (1975) 1.78
Fatal infectious mononucleosis in a family. N Engl J Med (1974) 1.73
Drug-induced active chronic hepatitis. Am J Dig Dis (1973) 1.70
Duality of hepatitis B antigen and its antibody. I. Immunofluorescence studies. J Infect Dis (1973) 1.65
Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N Engl J Med (1971) 1.60
Serial transmission in rhesus monkeys of an agent related to hepatitis-associated antigen. J Infect Dis (1972) 1.57
Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). N Engl J Med (1970) 1.50
Fatal infectious mononucleosis: a critical review. J Clin Pathol (1970) 1.46
Correlation of Australia antigen with posttransfusion hepatitis. JAMA (1970) 1.45
Etiologic relationship of marmoset-propagated CR326 hepatitis A virus to hepatitis in man. Proc Soc Exp Biol Med (1973) 1.45
Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations. JAMA (1970) 1.43
Viral hepatitis, type B (MS-2 strain). Detection of antibody after primary infection. N Engl J Med (1971) 1.39
Immunologic and electrophoretic heterogeneity of hepatitis-associated antigen. J Infect Dis (1971) 1.38
Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin. JAMA (1971) 1.38
Stability of the lipid and protein of hepatitis-associated (Australia) antigen. J Infect Dis (1971) 1.34
Subtypes of Australia antigen among patients and healthy carriers in Copenhagen. A relation between the subtypes and the degree of liver damage in acute viral hepatitis. N Engl J Med (1973) 1.30
Viral hepatitis, type B (MS-2 strain). Studies on active immunization. JAMA (1971) 1.29
D.N.A. polymerase in preparations containing Australia antigen. Lancet (1971) 1.27
Relation of hepatitis-B-antigen subtypes in symptom-free carriers to geographical origin and liver abnormalities. Lancet (1973) 1.23
Editorial: Subtypes of hepatitis B antigen: clinical relevance? Ann Intern Med (1973) 1.23
Antibody responses in viral hepatitis, type B. JAMA (1973) 1.23
The Ausria test: critical evaluation of sensitivity and specificity. Blood (1973) 1.13
Detection of Australia antigen by radioimmunoassay. Proc Natl Acad Sci U S A (1971) 1.13
Virus-like particles in Australia antigen-associated hepatitis. An immunoelectron microscopic study of human liver. Am J Pathol (1972) 1.08
Appraisal of the mortality in acute fulminant viral hepatitis. N Engl J Med (1968) 1.07
Seroepidemiological studies of transfusion-associated hepatitis. J Infect Dis (1971) 1.03
Electrn microscopic observations on virus-like particles associated with SH antigen. J Virol (1970) 1.02
Transmission of human hepatitis to marmosets: further coded studies. J Infect Dis (1971) 0.92
Letter: Nonspecificity of hepatitis B antigen detected with iodine-125-labeled antibody. Science (1973) 0.90
Hepatitis-free and stable human serum for intravenous therapy. Vox Sang (1971) 0.89
Granulomatous hepatitis associated with acute cytomegalovirus infection. Lancet (1973) 0.89
An electron microscopic study of the structural polymorphism of hepatitis B antigen. J Infect Dis (1973) 0.88
Acute viral hepatitis. Course and incidence of progression to chronic hepatitis. Am J Med (1973) 0.87
Risk of transfusing blood containing antibody to hepatitis-B surface antigen. Lancet (1974) 0.85
Failure of Australia antibody to prevent post-transfusion hepatitis. Lancet (1969) 0.81
Identification of the Kirk "hepatitis" virus as a member of the parvovirus (picodnavirus) group. Proc Soc Exp Biol Med (1971) 0.76
Hepatitis-associated antigen and antibody in cold ethanol fractionates of human blood. Vox Sang (1971) 0.76
Comparison of counterelectrophoresis and hemagglutination inhibition tests for hepatitis-associated antigen. Vox Sang (1972) 0.76
Similarity of hepatitis following transfusion of Australia-antigen positive and negative blood. Lancet (1973) 0.76
Letter: Varieties of HBAg. N Engl J Med (1974) 0.76
Detection of virus antigens: hepatitis B antigen. Metabolism (1973) 0.76
Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer. J Clin Invest (1973) 5.31
Detection of Australia antigen and antibody by means of radioimmunoassay techniques. J Infect Dis (1970) 3.89
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology (1991) 3.38
pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest (1975) 3.07
Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther (2000) 2.96
A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis (1969) 2.58
Pure human big gastrin. Immunochemical properties, disappearance half time, and acid-stimulating action in dogs. J Clin Invest (1974) 2.51
Gastrin release in postoperative ulcer patients: evidence for release of duodenal gastrin. Gastroenterology (1973) 2.47
Increased sensitivity to stimulation of acid secretion by pentagastrin in duodenal ulcer. J Clin Invest (1975) 2.08
Gastric acid secretion is abnormally sensitive to endogenous gastrin released after peptone test meals in duodenal ulcer patients. J Clin Invest (1980) 2.03
Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut (1992) 1.94
Gastrin (first of two parts). N Engl J Med (1975) 1.85
Zollinger-Ellison syndrome. Gastroenterology (1973) 1.79
Amino terminal gastrin fragment in serum of Zollinger-Ellison syndrome patients. Gastroenterology (1975) 1.68
The effect of atropine on plasma gastrin response to feeding. Gastroenterology (1971) 1.66
Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder. N Engl J Med (1979) 1.61
The effect of cimetidine, a new histamine H2-receptor antagonist, on meal-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcer. Gastroenterology (1976) 1.58
Clearance and acid-stimulating action of human big and little gastrins in duodenal ulcer subjects. J Clin Invest (1976) 1.57
The effect of an H2-receptor antagonist on food-stimulated acid secretion, serum gastrin, and gastric emptying in patients with duodenal ulcers. Comparison with an anticholinergic drug. J Clin Invest (1975) 1.56
The neuronal origin of bombesin-like immunoreactivity in the rat gastrointestinal tract. Neuroscience (1979) 1.56
Studies on the role of cephalic-vagal stimulation in the acid secretory response to eating in normal human subjects. J Clin Invest (1977) 1.55
Proof of a pyloro-oxyntic reflex for stimulation of acid secretion. Gastroenterology (1974) 1.51
Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome. Gastroenterology (1972) 1.50
Gastrin (second of two parts). N Engl J Med (1975) 1.49
A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. N Engl J Med (1989) 1.48
Gastrin, CCK, signaling, and cancer. Annu Rev Physiol (2001) 1.44
Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations. JAMA (1970) 1.43
Studies on the mechanisms of food-stimulated gastric acid secretion in normal human subjects. J Clin Invest (1976) 1.40
Cholecystokinin receptor antagonist MK-329 blocks intestinal fat-induced inhibition of meal-stimulated gastric acid secretion. Gastroenterology (1992) 1.40
Stimulation of gastric secretion and gastrin release by single oral doses of calcium carbonate in man. N Engl J Med (1973) 1.40
Effect of hamstring and psoas lengthening on pelvic tilt in patients with spastic diplegic cerebral palsy. J Pediatr Orthop (1999) 1.38
The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients. Gastroenterology (1976) 1.37
Intractable diarrhea. Intestinal perfusion studies and plasma VIP concentrations in patients with pancreatic cholera syndrome and surreptitious ingestion of laxatives and diuretics. Am J Dig Dis (1977) 1.36
Pure human minigastrin: secretory potency and disappearance rate. Gut (1974) 1.36
Role of gastrin heptadecapeptide in the acid secretory response to amino acids in man. J Clin Invest (1978) 1.32
Cholecystokinin-octapeptidelike immunoreactivity in human plasma. Gastroenterology (1982) 1.29
Bombesin-like peptides in mammals. Fed Proc (1979) 1.24
Amino acid sequences of three bombesin-like peptides from canine intestine extracts. J Biol Chem (1983) 1.23
Pancreatic polypeptide. Metabolism and effect on pancreatic secretion in dogs. Gastroenterology (1979) 1.22
Effect of naloxone and morphine on gastric acid secretion and on serum gastrin and pancreatic polypeptide concentrations in humans. Gastroenterology (1980) 1.19
Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience (2002) 1.18
Similar acid stimulatory potencies of synthetic human big and little gastrins in man. J Clin Invest (1984) 1.18
Regulation of gastric acid secretion. Annu Rev Physiol (1979) 1.16
Gastric and cephalic stimulation of human pancreatic polypeptide release. Gastroenterology (1978) 1.16
Effect of antral denervation on gastrin release by sham feeding and insulin hypoglycemia in dogs. Gastroenterology (1972) 1.14
Effect of truncal vagotomy on gastrin release and Heidenhain pouch acid secretion in response to feeding in dogs. Gastroenterology (1972) 1.12
Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 1.11
Effects of atropine and of antral acidification on gastrin release and acid secretion in response to insulin and feeding in dogs. Gastroenterology (1972) 1.11
Substance P-induced trafficking of beta-arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor. J Biol Chem (1999) 1.11
Vasoactive intestinal polypeptide. A neurotransmitter for lower esophageal sphincter relaxation. J Clin Invest (1984) 1.08
Partial structure of a large canine cholecystokinin (CCK58): amino acid sequence. Peptides (1982) 1.08
Secretion of type II phospholipase A2 and cryptdin by rat small intestinal Paneth cells. Infect Immun (1996) 1.08
Circulating gastrin in peptic ulcer disease. Mt Sinai J Med (1973) 1.08
Resting and pentagastrin-stimulated gastroesophageal sphincter pressure in patients with Zollinger-Ellison syndrome. Gastroenterology (1971) 1.08
Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects. J Clin Invest (1987) 1.07
High potency of bombesin for stimulation of human gastrin release and gastric acid secretion. Regul Pept (1981) 1.07
Effect of VIP infusion in water and ion transport in the human jejunum. Gastroenterology (1980) 1.06
Ontogenetic development and distribution of antibody transport and Fc receptor mRNA expression in rat intestine. Dig Dis Sci (1997) 1.06
Association of EB-virus infection with the post-perfusion syndrome. Lancet (1969) 1.05
Effect of atropine and vagotomy on pancreatic polypeptide response to a meal in dogs. Am J Physiol (1978) 1.05
Effect of gastric alkalinization on serum gastrin concentrations in humans. Gastroenterology (1983) 1.05
Somatostatin monoclonal antibody immunoneutralization increases gastrin and gastric acid secretion in urethane-anesthetized rats. Gastroenterology (1990) 1.04
Gastric acid secretory function in preterm infants. J Pediatr (1985) 1.04
PACAP type I receptor activation regulates ECL cells and gastric acid secretion. J Clin Invest (1999) 1.03
Calcitonin gene-related peptide and spinal afferents partly mediate postoperative colonic ileus in the rat. Surgery (1998) 1.03
Seroepidemiological studies of transfusion-associated hepatitis. J Infect Dis (1971) 1.03
Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. Am J Obstet Gynecol (1990) 1.03
Effects of inhibition of gastric secretion on antral gastrin and somatostatin gene expression in rats. Am J Physiol (1990) 1.02
Calcium challenge in the Zollinger-Ellison syndrome. Surgery (1972) 1.02
Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system. Brain Res Brain Res Rev (1998) 1.02
Stimulation of gastrin and somatostatin secretion from the isolated rat stomach by bombesin. Am J Physiol (1981) 1.02
Abnormal gastric function in longstanding, insulin-dependent diabetic patients. Gastroenterology (1979) 1.01
Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterology (1991) 1.01
Gastrin is a major mediator of the gastric phase of acid secretion in dogs: proof by monoclonal antibody neutralization. Gastroenterology (1989) 1.01
Pancreatic polypeptide response in patients with chronic pancreatitis. Dig Dis Sci (1979) 1.00
Effect of low-dose propantheline on food-stimulated gastric acid secretion: comparison with an "optimal effective dose" and interaction with cimetidine. N Engl J Med (1977) 1.00
Differential regulation of gastrin an somatostatin secretion from isolated perfused rat stomachs. Gastroenterology (1982) 1.00
The effect of octreotide on human gastric compliance and sensory perception. Neurogastroenterol Motil (1995) 1.00
Expression of cholecystokinin A receptors in neurons innervating the rat stomach and intestine. Gastroenterology (1999) 0.99
Increased serum gastrin concentrations and gastric acid hyposecretion in the immediate newborn period. Gastroenterology (1977) 0.99
Distribution of neurokinin-2 receptors in the guinea-pig gastrointestinal tract. Cell Tissue Res (1996) 0.99
Effect of atropine on vagal release of gastrin and pancreatic polypeptide. J Clin Invest (1979) 0.98
High basal gastric acid secretion in somatostatin receptor subtype 2 knockout mice. Gastroenterology (1998) 0.98
Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Gastroenterology (2000) 0.97
Childhood leukaemia in Ireland. Ir Med J (1992) 0.97
Evidence for oxyntopyloric reflex for release of antral gastrin. Gastroenterology (1975) 0.97
The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome. N Engl J Med (1976) 0.97
The somatostatin receptor subtype on rat enterochromaffinlike cells. Gastroenterology (1994) 0.97
Autonomous proliferation of colon cancer cells that coexpress transforming growth factor alpha and its receptor. Variable effects of receptor-blocking antibody. Gastroenterology (1992) 0.96
Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am J Physiol Gastrointest Liver Physiol (2000) 0.96
Bombesin stimulation of gastrin release from canine gastrin cells in primary culture. Am J Physiol (1987) 0.96
Requirement of cortical actin organization for bombesin, endothelin, and EGF receptor internalization. Am J Physiol Cell Physiol (2000) 0.96
Neuropeptides in sensory neurons. Life Sci (1982) 0.95
Somatostatin 2A receptor is expressed by enteric neurons, and by interstitial cells of Cajal and enterochromaffin-like cells of the gastrointestinal tract. J Comp Neurol (1997) 0.95
Gastrin mediates the gastric mucosal proliferative response to feeding. Am J Physiol (1996) 0.95
Evidence for and significance of the projection of VIP neurons from the myenteric plexus to the taenia coli in the guinea pig. Gastroenterology (1981) 0.95
Enzymatic degradation of C-terminal tetrapeptide amide of gastrin by mammalian tissue extracts. Fed Proc (1969) 0.95
Involvement of spinal calcitonin gene-related peptide in the development of acute visceral hyperalgesia in the rat. Neurogastroenterol Motil (2001) 0.94
Direct observation of endocytosis of gastrin releasing peptide and its receptor. J Biol Chem (1995) 0.94
Role of acetylcholine, histamine and gastrin in the acid response to intracisternal injection of TRH analog, RX 77368, in the rat. Regul Pept (1990) 0.94